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Introduction
Updated epidemiological data on the United States (US) 
population have recently described a continuous reduction 
trend of lung cancer incidence, even if it still remains the 
main cause of cancer mortality, estimating 72,500 new 
deaths in men and 63,220 in women for the 2020 (23% 
and 22% of all cancer deaths, respectively) (1). Similarly, 
in Europe lung cancer has the highest incidence rates 
in both sexes: female incidence has constantly risen up, 
overtaking breast cancer around 2016, while in 2019 
female lung cancer deaths have exceeded breast cancer 
ones (96,800 versus 92,800) (2). According to the World 
Health Organization (WHO) report, cancer is the second 
leading cause of death globally, and lung cancer has been 
responsible for an estimated 1.76 million deaths in 2018 (3). 
Particularly, in Italy we have recently witnessed a small and 
steady decrease of lung cancer incidence and mortality in 
men (−1.6%/year; −1.9%/year), along with a significant 
increase among women (+2.2%/year; +0.7%/year) (4). The 
patterns of lung cancer incidence worldwide are mainly 
dependent on tobacco consumption, being smoking habit 
cause by itself for over 80% of all lung cancer cases, with 
exposure to air pollution, radon, or chemicals, as well as 
a family history of lung cancer, likely accounting for the 
majority of the remaining cases (5).
Improving survival outcomes for the wide population of 
lung cancer patients means not only a deepener knowledge 
of disease biology leading the development of new 
treatment strategies, but also fighting the tobacco epidemic 
worldwide and concretely acting in terms of prevention. 
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The International Association for the Study of Lung 
Cancer (IASLC), along with many other scientific societies 
involved in this field, recognized that the solution to the 
tobacco problem lies in the primary prevention of tobacco 
initiation. The IASLC launched in 2019 a program called 
Lung Ambition Alliance with the ambitious goal to double 
5-year lung cancer survival by 2025 with different actions 
worldwide (https://www.lungambitionalliance.com). Indeed, 
it has become clear that the both cancer- and not cancer-
related mortality throughout adulthood smokers is 2–3 times 
the mortality observed in never-smokers, meaning an average 
10–20 years reduction of the overall life-expectancy (6). Another 
important goal to be pursued is the cessation of smoking 
attitude by individuals addicted to nicotine, since it has been 
largely demonstrated that stopping smoking works, leading 
to a significant gain of life expectancy of about 10, 9, and 
6 years for people who have stopped at 30, 40, or 50 years 
of age, respectively (7).
The 2013 World Health Assembly called on governments 
to adopt legislative measures aiming to reduce the smoking 
prevalence by about 30% within the year 2025 (8). The 
WHO Framework Convention on Tobacco Control 
recommended additional interventions, such as the WHO 
six-points MPOWER initiative, to further reduce tobacco 
consumption across different countries (9).
The rigorous adoption of several measures by European 
Governments, including limitations to whom and where 
tobacco can be sold, smoking ban in public places, 
cigarette price increase, shocking images on packages cover 
showing the dangerous effects of smoking, produced to an 
immediate drop out in cigarette consumption. However, 
additional efforts are needed by governments, scientific 
societies, health professionals, advocacy groups, journalists, 
and other opinion leaders, in order to aware public opinion 
and decision makers on smoking-related damages, since 
it became clear that a significant reduction in tobacco 
consumption would result in the prevention of a large 
fraction of lung cancers. In this review we will provide 
a summary of Women Against Lung Cancer in Europe 
(WALCE) commitment and experience in the field of 
smoking cessation and lung cancer prevention.
WALCE mission
WALCE is a non-profit European organisation born in 
2006 with the primary aim to increase women’s awareness 
about lung cancer in female population and to support 
patients and relatives during the difficult path of disease, 
focusing the attention also on the leading role of women 
as caregivers (10). Since the first years of activity, WALCE 
has been involved in multiple research projects concerning 
the better definition of gender differences in lung cancer 
and in primary prevention projects, trough educational 
materials and communication tools specifically designed 
and produced by the Association. WALCE also provides 
updated news about lung cancer, in terms of risk factors, 
early diagnosis, treatment modalities and related side 
effects, offering to patients and relatives the possibility to 
be adequately supported during the cancer care program, 
through an active involvement in multiple educational 
activities.
WALCE primary prevention campaigns
According to its mission, WALCE aims to promote 
communication strategies to aware public opinion and 
decision makers on damages of smoking on health. 
WALCE is coordinating different awareness initiatives, 
customized on recipients age. The idea to create prevention 
campaigns about tobacco damage on health on the basis of 
the different characteristics of the target population (age, 
sex, peculiar period of life, such as pregnancy), as well as the 
adopted communication channel for the campaign, is the 
real strength of the Association and, probably, the reason of 
the success achieved across the last years.
Children campaign
Aimed at 9–11-year-old pupils, “I’m not smoking that” 
(Figure 1) is a primary prevention campaign on smoking 
side effects on health endorsed by the National Institute 
of Health, offered by WALCE (for free) to Italian primary 
schools. After conducting a pilot experience, this primary 
prevention campaign started in 2011, immediately achieving 
great success. It is based on simple stories of everyday 
life, told by the protagonist children, characters in which 
pupils can easily identify themselves in order to tackle, with 
gradualness and lightness, important topics concerning 
health. Through an educational kit (composed by 
entertaining and illustrative contents specifically designed 
for children) in classrooms, teachers may promote positive 
attitudes aiming at healthy lifestyle and deviating from the 
smoking habit. WALCE also facilitates the intervention of 
a pulmonologist, when request by teachers who are able to 
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interactively illustrate the scientific aspects related to the 
innumerable smoking associated damages.
To date, over 24,000 pupils and 1,010 student classes 
have already joined the campaign. This material is available 
in Italian, French and English language.
Teens campaign
The book entitled “Ash of stars – Cinema, smoking habit 
and adolescents” focuses great attention on adolescence, 
pointing out the link between smoke scenes in recent 
movies and this habit in general population, especially 
in teens. European countries do not have any kind of 
legislation concerning the regulation of movies containing 
this type of scenes: WALCE aims to introduce stricter 
rules to limit the possibility of young people to access film 
containing unjustified smoking scenes and to avoid that 
movies become an instrument for tobacco advertising. 
Basing on cinematography, this book is a useful tool for 
teachers to stimulate discussion among students about 
smoking prevention and awareness programs.
The idea to design a prevention campaign dedicated 
only to teens rose from epidemiological data showing as the 
first cigarette is lit usually before the age of 18 (11); in Italy 
18.1 years, 17.6 for boys, 18.8 for girls (12). In the past 
few years, we are witnessing an increasing attitude to 
smoke among Italian teenagers, with 11% of “baby 
smokers” reported in 2018, representing one of the highest 
percentages in Europe. Teens are the most vulnerable part 
of society, but also those most exposed to smoking damages, 
since they are still growing, easily driven by emulation and 
influenced in their habits by unsuitable educational models.
The step succeeding “Ash of stars” has been “Blaam”, a 
digital project using an app as a tool, where people can point 
out smoke scenes in movie or TV series. The purpose of 
this project is to increase the awareness about the negative 
effects that smoking can produce (especially on teens) in 
movie scenes. The ambition is to attract the attention of the 
world of cinema on this topic and make it able to expose 
simple warnings before any movies.
Communication tools and initiatives for adult population
WALCE has also created a motivational web-based video, 
easy to use and extremely informative for the young-adult 
population illustrating smoking damage and the potential 
advantages derivated from quitting (13). This tool has been 
realized with the participation of exceptional testimonials 
(top-models, actors and sportsmen extremely popular in 
Italy and whose image was easily reconnected to a healthy 
lifestyle), and its capillarization still remains fundamental 
for the good performance of the same.
WALCE pursues the primary prevention aim through 
a campaign “in the field” named “Go out of the Tunnel. 
Don’t burn away your future”, a smoking prevention 
program addressed to general public, media and political 
institutions. This campaign consists on a structure shaped as 
a giant cigarette committing pulmonologists and oncologists 
to perform counseling, display educational materials on 
smoking cessation and provide a basic spirometry test to 
people attending. In Italy “Go out of the Tunnel” has been 
organized as a roadshow and, between 2015 and 2018, 
it has toured nine major Italian cities (Figure 2). Over 
15,000 people visited the Tunnel, involving groups of 
heterogeneous age (young people, adults and elderly) with 
more than 3,500 spirometries performed. The program has 
been endorsed by the Italian Parliament, and during the 
past years many celebrities and politicians have attended the 
Tunnel in order to sensitize media and political institutions 
to the tobacco problem.
At European level, during the World No-Tobacco Day 
Figure 1 “I’m not smoking that”, the WALCE’s primary 
prevention campaign designed for children (photo: original source, 
property of WALCE). WALCE, women against lung cancer in 
Europe.
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2017, a 2-day Tunnel exhibition took place in Brussels. As 
result, 450 spirometry have been performed and 600 people 
of any age, mainly smokers, joined the Tunnel asking 
information regarding smoke-related diseases and smoking 
cessation programs.
In 2019 WALCE, in cooperation with two major 
Spanish organizations, “Fundación MÁS QUE IDEAS” and 
“AEACaP-Asociación Española del Cáncer de Pulmón”, and 
endorsed by the IASLC, The Lung Ambition Alliance and 
“Fondazione Insieme contro il Cancro”, promoted a “Go 
out of the Tunnel” event focused on primary prevention 
and awareness on lung cancer, during the 20th World 
Conference on Lung Cancer—WCLC 2019, that took 
place in Barcelona, Spain. During this 2-day exhibition, 400 
people visited the tunnel and 124 spirometries have been 
performed.
Pregnant women
In order to complete the needs overview, in November 
2017 WALCE organised a smoking cessation campaign 
addressed to pregnant women, entitled “Hope it’s the 
last one”; the program was accompanied by a funny toy 
designed for the newborn child: “Ector the Protector Bear”, 
a teddy bear able to coughs if exposed to smoke. In parallel, 
a counseling service was also offered by gynecologists and 
pulmonologists, to promote healthy lifestyles.
Other relevant activities
Website
In the era of communication, digital reality is characterized 
by a fast stream of knowledge and a wide complexity 
of web-based articles which overtake the conventional 
communication modalities (newspapers, radio, television 
and often also scientific communications); in this context, 
for non-professionals, the possibility to discern between real 
and fake news is a right that must be protected.
The WALCE website is one of the most relevant 
“communication tools” of the Association, addressed to 
patients, friends, family members and anyone interested in 
knowing more about thoracic cancers. Through constant 
updating, the site provides everyone recent information, 
scientifically founded and controlled, accessible also for 
“non-sanitary” users.
Figure 2 “Go out of the Tunnel. Don’t burn away your future”, the prevention campaign offered by WALCE to general public, media and 
political institutions (photo: original source, property of WALCE). WALCE, women against lung cancer in Europe.
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Patients’ support
Primary WALCE’s missions is to inform, educate and 
support lung cancer patients and their families offering 
them orientation and updated services. To answer this need, 
the Association has created many information booklets, 
specifically designed for patients, including relevant issues 
in thoracic oncology, such as cancer diagnosis, modern 
strategies of treatment, management of side effects, smoking 
cessation strategies and disease communication skills within 
the family (with a particular attention to children). The 
booklets, available in Italian and English, are currently 
distributed during national and international scientific 
events by oncologists, pulmonologists, radiotherapists, 
pharmacists, thoracic surgeons and family doctors 
throughout the national territory.
November was declared by the Global Lung Cancer 
Coalition “Month of Worldwide awareness of lung 
cancer”, and on this occasion WALCE organizes numerous 
initiatives, including “How to feel better with a make-
up”. Since the first years of activity, in collaboration with 
oncology departments in Italy and other European cities, 
make-up laboratories are dedicated to patients undergoing 
cancer treatments, with the aim of sensitizing the population 
towards the pathology, give patients the opportunity to 
enhance their appearance and personality during such 
difficult period of their life, but also to favor those centers 
where programs like this do not exist on a regular basis.
Other activities offered to patients and caregivers 
during the path of illness are: “The mindfulness course”, 
small group events carried out with the close collaboration 
of psycho-oncologists in order to teach patients techniques 
that aim not to focus on the disease, but to develop 
freedom to live beyond cancer and strengthen internal and 
external resources by acquiring greater self-confidence; 
courses of relaxation techniques, art therapy workshops 
and open-air pet therapy with trained dogs; cooking 
lessons for patients and family members, carried out with 
experienced chefs on natural cuisine, able to illustrate 
the natural properties of some foods and put them into 
practice in recipes for daily use.
Patients’ care
Finally, in the recent years with the collaboration of some 
Pharma Companies and European researchers, has born 
EPROPA, a lung cancer patients support program designed 
and promoted by WALCE to offer equality in access to test, 
drugs and clinical trials across Europe. EPROPA main goal 
is to create a free-of-charge molecular screening platform for 
tumour characterization, in order to increase the detection 
of oncogenic drivers in lung cancer patients. The program 
will ensure teleconsulting to a National Reference Centre for 
patients with lung cancer to share clinical and pathological 
data. Tissue and plasma samples will be shipped to central 
laboratory for molecular screening and, on the basis of 
the results, to assess potential eligibility for therapeutic 
biomarker-driven clinical trials across Europe. The estimated 
turn-around time form samples shipment and tests results 
will be of 10 working days from sample reception. If the 
results will open the opportunity to enter in a dedicate 
clinical trial and the patient accepts to participate to this, 
EPROPA will help patients to reach the closest site where 
such study is available, covering for the cost of journey 
and staying of both patient and one caregiver during the 
experimental treatment. This extremely ambitious program 
well explains the heart of WALCE activity and its mission, 
in order to facilitate patient’s approach to the disease and 
optimize cancer treatment.
Conclusions
Today, the best way to create a safe and large support 
network for cancer patients and achieve a multidisciplinary 
management of the disease, is the steady involvement of 
dedicated advocacies and patient associations together with 
professionals involved in this field. After more than 10 
years from the first steps moved within the complex reality 
of patients’ care and families’ support, WALCE is now a 
well-established and recognised international association in 
the field of lung cancer: its dynamic activities, the careful 
care to any constituent of the society and its needs, the 
great energy of members and Association friends in every 
initiatives, make WALCE an example of patients advocacy 
largely committed to its mission and deeply integrated with 
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